Christopher Peetz - 03 Mar 2025 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Reporting relationship: CHIEF EXECUTIVE OFFICER, Director
Issuer ticker: MIRM
Reported as of: 03 Mar 2025
Net transaction value: -$1,758,913
SEC form: 4
Accepted by SEC: 04 Mar 2025, 16:26:16 UTC
Prior SEC filing: 04 Feb 2025
Next SEC filing: 18 Mar 2025
Source filing: View source filing
Reporting owner signature: /s/ Judit Ryvkin, Attorney-in-Fact

Key filing fact

Christopher Peetz filed Form 4 for Mirum Pharmaceuticals, Inc. (MIRM) on 04 Mar 2025.

Key facts

This page summarizes Christopher Peetz's Form 4 filing for Mirum Pharmaceuticals, Inc. (MIRM).
4 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 04 Mar 2025, 16:26.

Change

Previous filing in this sequence was filed on 04 Feb 2025.
Current net transaction value: -$1,758,913.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MIRM transaction

Common Stock

Options Exercise

Transaction value: $117,440
Shares: +40,000
Change %: +35%
Price: $2.94
Shares after: 155,920
Date: 03 Mar 2025
Ownership: Direct

MIRM transaction

Common Stock

Sale

Transaction value: $903,861
Shares: -19,392
Change %: -12%
Price: $46.61
Shares after: 136,528
Date: 03 Mar 2025
Ownership: Direct
Footnotes: F1, F2

MIRM transaction

Common Stock

Sale

Transaction value: $972,492
Shares: -20,608
Change %: -15%
Price: $47.19
Shares after: 115,920
Date: 03 Mar 2025
Ownership: Direct
Footnotes: F1, F3

MIRM holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 208,570
Date: 03 Mar 2025
Ownership: By The Peetz Family Trust

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MIRM transaction Derivative

Employee Stock Option (right to buy)

Options Exercise

Transaction value: $0
Shares: -40,000
Change %: -14%
Price: $0.000000
Shares after: 238,487
Date: 03 Mar 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 40,000
Exercise price: $2.94
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 4 footnotes

Footnote F1

Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on November 22, 2024.

Footnote F2

The weighted average sale price for the transaction reported was $46.61, and the range of prices were between $45.82 and $46.81. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

Footnote F3

The weighted average sale price for the transaction reported was $47.19, and the range of prices were between $46.82 and $47.78. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.

Footnote F4

The stock option is fully vested.